These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 5117146

  • 1. [Preliminary report on out-patient intermittent drug therapy in cases of active sputum-positive pulmonary tuberculosis].
    Zielniewicz B, Klimczyk M, Chodera B.
    Gruzlica; 1971 Jul; 39(7):668-70. PubMed ID: 5117146
    [No Abstract] [Full Text] [Related]

  • 2. [Proceedings: Results of a controlled trial of intermittent ambulatory therapy of infectious pulmonary tuberculosis with comparison of various maintenance regimens].
    Ganguin HG, Cramer G, Götz J, Holzhauer H, Niegsch G, Sieler H, Velten G, Völker L.
    Z Erkr Atmungsorgane Folia Bronchol; 1973 Jul; 138(1):107-15. PubMed ID: 4203235
    [No Abstract] [Full Text] [Related]

  • 3. [Effectiveness and possibilities of application to ambulatory patients in our region of a pulmonary tuberculosis therapy by the intermittent administration (I.V.) of the triple association isoniazid-streptomycin-PAS (preliminary results after a year)].
    Burghard G, Petitjean R, Schranz J, Scherrer B.
    Rev Tuberc Pneumol (Paris); 1970 Jul; 34(3):439-53. PubMed ID: 5515514
    [No Abstract] [Full Text] [Related]

  • 4. [Comparative study on an intermittent mode of pulmonary tuberculosis therapy using streptomycin and isoniazid].
    Burzibu JM, Durante C, Ceicu A, el Fassi el Fahri M, Bahsoun H.
    Maroc Med; 1974 May; 54(579):307-13. PubMed ID: 4444314
    [No Abstract] [Full Text] [Related]

  • 5. Tuberculosis chemotherapy and sputum conversion among HIV-seropositive and HIV-seronegative patients in south-eastern Uganda.
    Bwire R, Borgdorff MW, Sticht-Groh V, Rieder HL, Kawuma HJ, Bretzel G, Rüsch-Gerdes S.
    East Afr Med J; 1999 Jun; 76(6):307-13. PubMed ID: 10750516
    [Abstract] [Full Text] [Related]

  • 6. [Ambulatory intermittent chemotherapy of patients with newly detected pulmonary tuberculosis].
    Rudoĭ NM, Simonian LK.
    Klin Med (Mosk); 1973 Jul; 51(7):89-92. PubMed ID: 4786268
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Modified short-course chemotherapy of pulmonary tuberculosis in Ibadan, Nigeria--a preliminary report.
    Ige OM, Bakare NA, Onadeko BO.
    Afr J Med Med Sci; 2000 Mar; 29(1):51-3. PubMed ID: 11379469
    [Abstract] [Full Text] [Related]

  • 9. Comparative controlled trial of rimactane in pulmonary tuberculosis.
    Dormer BA.
    Int Z Klin Pharmakol Ther Toxikol; 1969 Apr; 2(2):188. PubMed ID: 4895449
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Intermittent chemotherapy with isoniazid and streptomycin in Algiers.
    Chaulet P, Larbaoui D, Grosset J, Abderrahim K.
    Tubercle; 1967 Jun; 48(2):128-36. PubMed ID: 6058030
    [No Abstract] [Full Text] [Related]

  • 12. Should we take a history of prior treatment, and check sputum status at 2-3 months when treating patients for tuberculosis?
    Wilkinson D, Bechan S, Connolly C, Standing E, Short GM.
    Int J Tuberc Lung Dis; 1998 Jan; 2(1):52-5. PubMed ID: 9562111
    [Abstract] [Full Text] [Related]

  • 13. [Streptomycin, isoniazid and ethambutol in continuous and intermittent treatment of previously untreated pulmonary tuberculosis].
    Zierski M, Bek E.
    Gruzlica; 1972 Jan; 40(12):1165-74. PubMed ID: 4648079
    [No Abstract] [Full Text] [Related]

  • 14. [The problem of infectiousness of tuberculosis patients during chemotherapy].
    Schulthess HK, Zollikofer H.
    Schweiz Med Wochenschr; 1981 Feb 21; 111(8):251-4. PubMed ID: 6785880
    [Abstract] [Full Text] [Related]

  • 15. Results of one-year chemotherapy with isoniazid (INH), streptomycin (SM) and ethionamide (ETA) in previously untreated patients with cavernous pulmonary tuberculosis.
    Zajaczkowska J, Krychniak W, Krakówka P, Buraczewska M.
    Pol Med J; 1966 Feb 21; 5(2):339-44. PubMed ID: 5915720
    [No Abstract] [Full Text] [Related]

  • 16. Factors influencing time to smear conversion in patients with smear-positive pulmonary tuberculosis.
    Wang JY, Lee LN, Yu CJ, Chien YJ, Yang PC, Tami Group.
    Respirology; 2009 Sep 21; 14(7):1012-9. PubMed ID: 19659516
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Results of routine treatment of pulmonary tuberculosis patients treated for the 1st time].
    Bernard E, Abadi O, Pretet S.
    Rev Tuberc Pneumol (Paris); 1969 Nov 21; 33(7):967-74. PubMed ID: 5402999
    [No Abstract] [Full Text] [Related]

  • 19. [Interrupted treatment with streptomycin and tubazid of patients with pulmonary tuberculosis].
    Ginzburg EA, Levtonova EV, Kaliamova RF, Shilova MV, Samarin MS.
    Vrach Delo; 1973 Feb 21; 2():66-9. PubMed ID: 4722335
    [No Abstract] [Full Text] [Related]

  • 20. Concurrent comparison of an unsupervised daily oral regimen of thiacetazone plus isoniazid and a fully supervised twice-weekly regimen of streptomycin plus isoniazid in the domiciliary treatment of pulmonary tuberculosis--a co-operative investigation.
    Menon K.
    Bull Int Union Tuberc; 1974 Aug 21; 49 suppl 1():131-2. PubMed ID: 4143180
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.